NB Bancorp, Inc. focuses on operating as a bank holding company for Needham Bank that provides various banking products and services in the Greater Boston metropolitan area and surrounding communities in the United States. The company offers various deposits, including certificate of deposit, individual retirement, money market, savings, NOW, demand deposit, and interest-bearing and noninterest-bearing checking accounts; and commercial real estate and multifamily residential loans, one- to four-family residential real estate, mortgage warehouse loans, construction and land development, commercial and industrial, and consumer loans, as well as home equity loans and lines of credit. It also invests in securities consisting of U.S. treasury and federal agency securities, government-sponsored residential mortgage-backed securities, corporate bonds, SBA securities and municipal bonds. NB Bancorp, Inc. was founded in 1892 and is based in Needham, Massachusetts.…
IPO Stock Of The Week: NB Bancorp Hits Early Buy Point Despite Weak Market Environment
NB Bancorp (NASDAQ: NBBK) is listed on Nasdaq, where its shares trade in USD. It belongs to the Banks - Regional industry, part of the Financial Services sector, and reports about 526 employees.
The shares were at 21.06 USD on 20 November 2026, up 14.5% over 52 weeks. Its 52-week range is 18.11 USD to 23.47 USD: the price is 10.3% below the high and 16.3% above the low.
At a market capitalisation of 922.82M USD, it trades at 12.6 times trailing earnings and 8.4 times forward earnings. The median trailing P/E of its 20 largest Banks - Regional peers is 10.3, a premium of 23% for NBBK. It pays a dividend yielding 1.33% (it pays out 17% of its earnings), against a median of 4.16% among the dividend payers in that peer group.
NB Bancorp reports return on equity of 5.9%, an operating margin of 42.6% and revenue up 49.2% year over year.
It holds more cash than debt, a net cash position of 115.73M USD. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. 2 analysts cover the stock; their mean price target of 25.00 USD is 18.7% above the current price. The next earnings report is expected on 21 January 2027.